Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxysterols in Breast Cancer Patients on Hormonal Therapy
NCT01553903Phase 4Completed
- Sponsor
- Institut Claudius Regaud
- Start
- Dec 2011
- Primary completion
- May 2013
- Modality
- Irreversible Covalent Inhibitors, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of tamoxifen, exemestane, anastrozole, letrozole in breast cancer, sponsored by Institut Claudius Regaud. Started Dec 2011; status: completed.
02
Drugs
tamoxifenexemestaneanastrozoleletrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01553903.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01553903.